Company Overview and News
Franco-Nevada is trading at a market cap of USD13.7 billion at the moment and the price of stock currently stands around USD 73.6 billion which is expensive in my opinion.
FNV.WT.A FNV FNV
Editor’s note: Below, you’ll find the latest essay in Matt McCall’s series on how to make money during the coming marijuana boom. In this essay, Matt reveals what could turn out to be the ultimate way to invest in legal marijuana.
RGLD FNV.WT.A SLW FNV SLW FNV RGL
2018-06-07 investorplace - 1
Once again, gold stocks are struggling. The VanEck Vectors Gold Miners ETF (NYSEARCA:GDX) and the VanEck Vectors Junior Gold Miners ETF (NYSEARCA:GDJX) both have dropped about 13% from January highs. Both ETFs are down YTD as well — with performance lagging the S&P 500.
WPM TAHO FNV.WT.A ABX FNV AU K GDX SLW AULGF RGLD THO SLW KGC AGG IAG GG FNV RGL ABX GDXJ
2018-06-05 seekingalpha - 1
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
HRT MGG HRTFF MMRGF GFI.WI FNV NEM NMKEF RSG PRB RNX RNKLF KGC NMX RMGGF FQVLF AEM MACIF AG FQM GFIOF NDM WPM RPM FR SAND FNV.WT.A SSL GPL SDDXF ALO PROBF K RPMGD WHGOF RPMGF SNXZF ORG RGLD RNX.WT RMGGY GFI PGLC CANWF FNV RGL
2018-05-21 investorplace - 6
Although the markets have their own logic, highly capitalized gold-mining companies seemingly should belong on any “stocks to buy” list. Thanks to rising geopolitical tensions and soaring trading sentiment, many folks seek safe-haven assets. While gold stocks seemingly offer a viable solution, their overall performance has been unusually disappointing.
HMY NCMGF NCM GFI.WI FNV NEM EVN YRI NGDAF BVN NGD RRS AGI SLW KGC BTG AUY AMGGF AEM CAHPF GFIOF IAG GG HGMCF EGO ABX WPM FNV.WT.A NGD ABX RGORF K GOLD AGI SLW GOLD RGLD NCMGY ELD GFI FNV RGL
After an extremely busy week last week, there are only two Canadian Dividend All-Stars scheduled to report earnings this coming week. Unfortunately, neither are expected to increase dividends. However, we have plenty to catch up on from last week before banks start to report in two weeks.
FINGF FNV.WT.A LSDAF FNV KEYUF OTEX CIFAF FTT T LAS.A WN AQN OTC ONEXF KEY CIX TU FNV
Strap yourselves in, it is going to be a very busy week. It will be one of the busiest weeks of the year as there are 35 Canadian Dividend All-Stars scheduled to report earnings this coming week. The great news is that investors can also expect a slew of dividend raises this week. Before we dive into the coming week, let’s take a look at last week’s results.
PPL FNV.WT.A LBLCF LSDAF FNV KEYUF OTEX L CIFAF CPXGF LAS.A WN OTC ONEXF CIX CGX PBA TU FNV
2018-04-27 seekingalpha - 1
Eldorado Gold posted a gain of $8.718 million, or $0.01 per share, for the first quarter. Revenues were $131.91 million up 17.9% from a year ago and up 30% sequentially.
SAND SSL ICG FNV.WT.A SDDXF ABX FNV NEM DTK SNXZF ICGQF ELD FNV EGO ABX
In this part of our series, we’ll be looking at the correlation between gold and four mining stocks: New Gold (NGD), Newmont Mining (NEM), Franco-Nevada (FNV), and Randgold Resources (GOLD). Mining stocks mostly move with gold prices but not always. Among these four miners, Newmont has shown the highest correlation to gold, while Franco Nevada has seen the lowest correlation on a YTD (year-to-date) basis.
FNV.WT.A NGD FNV NEM RGORF NGDAF GOLD RRS NGD FNV GOLD
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...